High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: A prospective, randomized, controlled trial

Human Reproduction

Volumn 15, Issue 11, 2000, Pages 2292-2296

  Garcia Velasco, Juan A ^a,c   Isaza, Verónica ^a   Requena, Antonio ^a   Martínez Salazar, Fco Javier ^a   Landazábal, Adriana ^a   Remohí, José ^b   Pellicer, Antonio ^b   Simón, Carlos ^b  

^a IVI Madrid   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c IVI Madrid   (Spain)

Author keywords

GnRH analogue; Gonadotrophin; IVF; Low responders

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; NEOFERTINORM; PROGEFFIK; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; OOCYTE MATURATION; OVULATION INDUCTION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0033767616     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.11.2292     Document Type: Article

References (29)

1. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: A prospective study using transvaginal color Doppler sonography
2. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization
3. The use of transvaginal power Doppler ultrasonography to evaluate the relationship between perifollicular vascularity and outcome in in-vitro fertilization treatment cycles
4. Influence of weight in the induction of ovulation with human menopausal gonadotropin and human chorionic gonadotropin
5. IVF: Induction of ovulation in poor responders
6. Cessation of gonadotrophin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH - A protocol in poor responders undergoing in vitro fertilization
7. Value of ovarian stromal blood flow velocity measurement after pituitary suppression in the prediction of ovarian responsiveness and outcome of in vitro fertilization treatment
8. Cessation of gonadotrophin-releasing hormone agonist therapy combined with high-dose gonadotrophin stimulation yields favorable pregnancy results in low responders
9. Human menopausal gonadotrophin/human chorionic gonadotrophin follicular maturation for oocyte aspiration: Phase II, 1981
10. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, mid luteal or late luteal phase in normally cycling women
11. Efficacy of intracytoplasmic sperm injection using testicular spermatozoa
12. Exogenous gonadotropin requirements are increased in leuprolide suppressed women undergoing ovarian stimulation
13. A rational approach to the management of low responders in in-vitro fertilization
14. Ovarian estradiol production in vivo. Inhibitory effect of leuprolide acetate
15. High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome
16. Poor responders to ovulation induction: Is proceeding to in-vitro fertilization worthwhile?
17. GnRH receptors in human granulosa cells: Anatomical localization and characterization by autoradiographic study
18. The association between pre-ovulatory serum 17-β estradiol pattern and conception in human premenopausal gonadotrophin-human chorionic gonadotrophin stimulation
19. Outcome of in vitro fertilization in women with low response to ovarian stimulation
20. Ovarian response and outcome of in-vitro and fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of the menstrual cycle
21. Evaluation of the ovarian reserve in young low responders with normal basal levels of follicle-stimulating hormone using three-dimensional ultrasonography
22. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization
23. Evaluation and treatment of low responders
24. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulation quality in in vitro fertilization
25. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen
26. Profound luteinizing hormone suppression after stopping the gonadotrophin releasing hormone-agonist leuprolide acetate
27. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization
28. Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: A randomized study
29. Gonadotrophin-binding sites in the Rhesus monkey ovary: Role of the vasculature in the selective distribution of human chorionic gonadotrophin to the preovulatory follicle